In the Editorial titled “Should Patients Take Aspirin for Primary Cardiovascular Prevention? Updated Recommendations From the US Preventive Services Task Force” published in the April 26, 2022, issue of JAMA, a data point appeared incorrectly. In the paragraph beginning “The basis for these new recommendations is an updated review,” the range of absolute differences for composite and individual major bleeding events, reported as 0.07 fewer events to 1.0 more events per 100, should have read 0.2 fewer events to 1.0 more events per 100. This article was corrected online.
Source: JAMA Online First